Abstract
A 53-yr-old Caucasian woman presents to her primary care physician for advice regarding her concerns about developing osteoporosis. The reason she is anxious is that her mother has osteoporosis, a great deal of back pain, and a prominent thoracic spine deformity (dowager’s hump). The patient’s menopause occurred 12 mo ago, and has been associated with minimal vasomotor symptoms. She is generally in good health. Her only medications are L-thyroxine (0.15 mg daily) for hypothyroidism and 25 mg daily of hydrochlorozide for mild hypertension. The patient has a good appetite, but she cannot tolerate dairy products owing to lactose intolerance. A dietary history reveals that her daily calcium intake is about 700 mg.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Holick MF. Vitamin D requirements for the elderly. Clin Nutr 1986; 5: 121–129.
Watts NB, Harris ST, Genant HK, et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. NEngl JMed 1990; 323: 73–79.
Ott SM, Chestnut CH III. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Ina Med 1989; 110: 267–274.
Riggs BL, Hodgson SF, O’Fallon WM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. NEngl JMed 1990; 322: 802–809.
Heaney RP, Recker RR, Saville PD. Menopausal changes in calcium balance performance. JLab Clin Med 1978; 92: 953–963.
NIH Consensus Conference. Optimal calcium intake. JAMA 1994; 272: 1942–1948.
Dawson-Hughes B, Dallai GE, Kroll EA, et al. A controlled trial ofthe effect of calcium supplementation on bone density in postmenopausal women. NEngl JMed 1990; 323: 878–883.
Matkovic V, Kostal K, Simonvic I, et al. Bone status and fracture rates in two regions of Yugoslavia. Am J Clin Nutr 1979; 32: 540–549.
Reid IR, Ames RW, Evans MC, et al. Effective calcium supplementation on bone loss in postmenopausal women. NEngl JMed 1993; 328: 460–464.
Dalsky GP, Stocke KS, Ehsani AA, et al. Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women. Ann Intern Med 1988; 108: 824–828.
Cavanaugh DJ, Cann CE. Brisk walking does not stop bone loss in postmenopausal women. Bone 1988; 9: 201–204.
Aloia JF, Cohn SH, Ostuni JA, et al. Prevention of involutional bone loss by exercise. Ann Intern Med 1978; 84: 356–358.
Kannus P, Haapasalo H, Sankelo M, et al. Effect of starting age of physical activity on bone mass in the dominant arm of tennis and squash players. Ann Intern Med 1995; 123: 27–31.
Jones HH, Priest JD, Hayes WC, et al. Humeral hypertrophy in response to exercise. J Bone JtSurg 1977; 59-A: 204–208.
Forwood MR, Burr DB. Physical activity and bone mass: exercises in futility? Bone Miner 1993; 21: 89–112.
Sattin RW. Falls among older persons: a public health perspective. Ann Public Health 1992; 13: 489–508.
Kiel DP, Felson DT, Anderson JJ, et al. Hip fracture and the use of estrogens in postmenopausal women: the Framingham study. NEngl J Med 1987; 317: 1169–1174..
Lindsay R, Hart DM, Aitken JM, et al. Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet 1976: 1038–1040.
Lindsay R, Tohme JF. Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol 1990; 76: 290–295.
Bush TL, Barrett-Conor E, Cowan LD, et al. Cardiovascual mortality in noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987; 75: 1102–1109.
Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten year follow-up from the Nurses’ Health Study. N Engl JMed 1991; 325: 756–762.
Sullivan JM, Vander Zwaag R, Lemp GF, et al. Postmenopausal estrogen use and coronary atherosclerosis. Ann Int Med 1988; 108: 358–363.
Brinton LA, Schairer C. Estrogen replacement therapy and breast cancer risk. Epidemiol Rev 1993; 15: 66–79.
Dupont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991; 151: 67–72.
Steinberg KK, Thacker SB, Smith JS, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991; 265: 1985–1990.
Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. NEngl JMed 1995; 332: 1589–1593.
Hui SL, Slemenda CW, Johnston CC. Baseline measurements of bone mass predicts fracture in white women. Ann Intern Med 1989; 111: 355–361.
Wartofsky L. Levothyroxine therapy and osteoporosis. Arch Int Med 1995; 155: 1130–1131.
Slemenda CW, Christian JC, Hui S, et al. No evidence for an effect of lactase deficiency on bone mass in pre-or postmenopausal women. J Bone Miner Res 1991; 6: 1367–1371.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Levin, R.M. (1996). Prevention of Osteoporosis. In: Rosen, C.J. (eds) Osteoporosis. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0221-9_17
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0221-9_17
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-6668-6
Online ISBN: 978-1-4612-0221-9
eBook Packages: Springer Book Archive